MAY 05, 2021 8:00 AM PDT

The Impact of SARS-CoV-2 Genomic Surveillance Locally, Nationally, and Globally

Speaker
  • Associate Dean of Professional Program and Graduate Affairs - Northeastern University
    Biography

      Jared R. Auclair is currently the Associate Dean of Professional Program and Graduate Affairs in the College of Science at Northeastern University and Associate Teaching Professor in the department of chemistry and chemical biology. In addition, Dr. Auclair is the Director of the Biopharmaceutical Analysis Laboratory (BATL), the Asia-Pacific Economic Cooperation Center of Regulatory Excellence in Biotherapeutics and Advanced Therapies and oversees the International Council for Harmonisation training. Lasting, Prof. Auclair serves as the Technical Supervisor for the Life Science Testing Center at Northeastern University, which is a state and CLIA-certified lab. Dr. Auclair collaborate with both academic researchers, industry, and government in the area of biopharmaceutical development and analysis. He has expertise in mol. biology, protein biochemistry, analytical chemistry, protein crystallography, and biological mass spectrometry; and is interested in use inspired research for the biotechnology industry.


    Abstract

    Date:  May 5, 2021

    Time: 8:00am PDT, 11:00am EDT, 5:00pm CET

     

    Emergence of genetic mutations within the SARS-CoV-2 genome that may enhance transmissibility, increase symptom severity or improve the virus’s ability to evade immunity produced by current vaccines, have raised concerns around the world.   Learn from two colleagues that have pivoted lab efforts to enable SARS-CoV-2 mutation surveillance at a local and national level.

     

    Testing and Surveillance of SARS-CoV-2 Variants to Enable Safe Return to On-campus Learning

     

    In March of 2020, like other Universities, Northeastern University (Boston, MA) moved all instruction online and shortly there after closed campus down.  Almost immediately after the University started to plan for its reopening in Fall of 2022.  In this presentation, we will briefly look at Northeastern Universities response to COVID-19 through testing as well as the importance of genomic surveillance as the number of variants reported increases.   

     

    SARS CoV-2 testing and sequencing for international arrivals reveals significant cross border transmission of high risk variants into the United Kingdom

     

    Mandatory Day 2 and Day 8 PCR testing of international arrivals has been recently introduced by the UK Government to mitigate against the cross-border transmission of high risk SARS-CoV-2 variants. All positive Day 2 samples with cycle threshold (Ct) values of <30 (defined as equivalent to ~10,000-1,000 viral genome copies/ml) must undergo genomic sequencing. Oncologica is a participant in this testing program and utilizes a novel integrated test and sequence workflow to detect and identify variants. Here we have conducted a retrospective analysis of SARS-CoV-2 test data to determine the prevalence and variant type entering the UK.

     

     

    Learning Objectives:

    • Learn how academic and public health laboratories are implementing SARS-CoV-2 genome sequencing for surveillance and tracking of variants within localized populations
    • Be introduced to contributions toward regional and national genomic surveillance efforts by private laboratories
    • Gain an understanding of the importance in having a strong national surveillance program in parallel with a robust network of local and regional labs to enable rapid, public health response to outbreaks.

     

     

    Webinars will be available for unlimited on-demand viewing after live event.


    Show Resources
    You May Also Like
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    Loading Comments...
    Show Resources
    Attendees
    • See more